Latanoprost Actavis

Latanoprost, the active ingredient in Latanoprost Actavis, is a prostaglandin analog presented as a topical ophthalmic solution for ocular use. It lowers intra‑ocular pressure and is used in the management of open‑angle glaucoma and ocular hypertension in adult patients.

GNH USA supplies Latanoprost Actavis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanoprost Actavis belongs to the prostaglandin analog class and is used to manage conditions that involve elevated intra‑ocular pressure. - Open‑angle glaucoma: reduces intra‑ocular pressure to slow disease progression. - Ocular hypertension: lowers pressure to prevent conversion to glaucoma. - Secondary open‑angle glaucoma: helps control pressure when caused by other ocular conditions.

Latanoprost may cause ocular and systemic reactions, most of which are mild and reversible.

Common Side Effects: - Eye redness: mild conjunctival hyperemia. - Itching or burning sensation: transient ocular discomfort. - Increased iris pigmentation: gradual darkening of the iris color. - Eyelash growth: longer, thicker lashes. - Blurred vision: temporary visual disturbance after instillation. - Eye discharge: mild tearing or watery eyes.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, rash, or difficulty breathing. - Eye pain or severe irritation: may indicate inflammation. - Vision loss: sudden decrease in visual acuity. - Uveitis or iritis: intra‑ocular inflammation requiring medical attention. - Corneal edema: swelling of the cornea affecting clarity. - Periorbital fat atrophy: loss of orbital fat tissue.

Before using Latanoprost Actavis, consider the following safety measures. - Pregnancy: safety not established; avoid unless clearly needed. - Breastfeeding: unknown excretion; weigh benefits against potential risks. - Active ocular inflammation: contraindicated until inflammation resolves. - Intra‑ocular pressure monitoring: assess response after initiation. - Concomitant eye drops: wait at least 5 minutes between applications. - Store at room temperature: keep in original container, protect from light and moisture.

Latanoprost may interact with other ocular or systemic agents.

Major Interactions (Avoid): - Other prostaglandin analogs (e.g., bimatoprost): additive pressure‑lowering effect may cause excessive reduction. - Ocular anesthetics: increased risk of corneal irritation.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory eye drops: may alter ocular surface tolerance. - Systemic beta‑blockers: additive intra‑ocular pressure reduction. - Anticholinergic agents: potential impact on tear production. - Topical corticosteroids: may diminish Latanoprost efficacy.